John Connelly

1.7k citations

36 papers · 1.1k indexed · h-index 16

Impact in

Hematology top 10%
- Iron Metabolism and Disorders
Genetics top 10%
- Hemoglobinopathies and Related Disorders

Papers in

Virology 2
Genetics 4
- Hemoglobinopathies and Related Disorders 4

Co-authors: Michael Spino Fernando Tricta Anne Monks Antonio Martín‐Bastida David T. Dexter Roberta J. Ward Maneesh C. Patel Robert R. Crichton
Journals: PLoS ONE (3 papers)Molecular Cancer Therapeutics (2 papers)Scientific Reports (2 papers)Molecular Pharmacology (2 papers)German Studies Review (2 papers)
Partner nations: United States Canada Germany

In The Last Decade

John Connelly

32 papers receiving 1.0k citations

Peers

Countries citing papers authored by John Connelly

Since Specialization

Citations

This map shows the geographic impact of John Connelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Connelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Connelly more than expected).

Fields of papers citing papers by John Connelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Connelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Connelly. The network helps show where John Connelly may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John Connelly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Connelly Line = papers co-authored together John Connelly links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Metagenomic DNA sequencing to quantify Mycobacterium tuberculosis DNA and diagnose tuberculosis Scientific Reports ·Isra Alam, Long Chen, K. Viswanath, Joan Sesing Lenz, Philip Burnham, Marie-Josèphe Foy, Alfred Andama, John Connelly, Christine Bachman, Adithya Cattamanchi, Lollar Christina, Iwijn De Vlaminck	2022	4
2	Multiplexed and Extraction-Free Amplification for Simplified SARS-CoV-2 RT-PCR Tests Analytical Chemistry ·Samantha A. Byrnes, Ryan Gallagher, Lollar Christina, Crissa Bennett, Iain Moncrieffe, Corrie Ortega, S. Timothy Motley, Paras Jain, Bernhard H. Weigl, John Connelly	2021	47
3	Antibody Screening Results for Anti-Nucleocapsid Antibodies Toward the Development of a Lateral Flow Assay to Detect SARS-CoV-2 Nucleocapsid Protein ACS Omega ·David M. Cate, Joshua D. Bishop, Helen V. Hsieh, Veronika Glukhova, Luis F. Alonzo, J Bryniarski, D. E. Barkovsky, Benjamin D. Grant, Caitlin E. Anderson, F. Baur, Weibin Xu, Ryan Gallagher, Iain Moncrieffe, Crissa Bennett, Samantha A. Byrnes, John Connelly, Puneet Dewan, David S. Boyle, Bernhard H. Weigl, Kevin P. Nichols	2021	19
4	Action of iron chelator on intramyocardial hemorrhage and cardiac remodeling following acute myocardial infarction Basic Research in Cardiology ·S. Rossbach, Jill J. Weyers, Xiuling Qi, Jennifer Barry, G N Shevko, D. Manca, John Connelly, Michael Spino, John C. Wood, Bradley H. Strauss, Graham A. Wright, Nilesh R. Ghugre	2020	32
5	Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets Clinical Epigenetics ·Julia Krushkal, Thomas Silvers, William C. Reinhold, Dmitriy Sonkin, Aidan Beatty, John Connelly, Sudhir Varma, Paul S. Meltzer, Mark W. Kunkel, Annamaria Rapisarda, David M. Evans, Yves Pommier, Beverly A. Teicher	2020	50
6	Exposure time versus cytotoxicity for anticancer agents Cancer Chemotherapy and Pharmacology ·David M. Evans, Jianwen Fang, Thomas Silvers, René Delosh, Julie Laudeman, Benjamin Ackermann, Russell Reinhart, Michael Selby, Vacca, John Connelly, Erik Harris, Julia Krushkal, Larry Rubinstein, James H. Doroshow, Beverly A. Teicher	2019	22
7	Ultrasensitive detection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of HIV negative patients with tuberculosis PLoS ONE ·Collin Maxon, Syed Barizuddin, M Stengel, Cherian J. Mathai, Alexey Ball, K Minch, Ákos Somoskövi, Beston Hamasur, John Connelly, Bernhard H. Weigl, Alfred Andama, Adithya Cattamanchi, Keshab Gangopadhyay, Sangho Bok, Shubhra Gangopadhyay	2019	16
8	Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease Scientific Reports ·Antonio Martín‐Bastida, Roberta J. Ward, Rexford D. Newbould, Paola Piccini, David Sharp, Demetrios Chrysis, Maneesh C. Patel, Michael Spino, John Connelly, Fernando Tricta, Robert R. Crichton, David T. Dexter	2017	295
9	Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial PLoS ONE ·Deepti Saxena, Michael Spino, Fernando Tricta, John Connelly, Bernadette Cracchiolo, Axel-Rainer Hanauske, Ashwath Rohit, Michael B. Mathews, Jonathan Karn, Bart Holland, Myung Hee Park, Tsafi Pe’ery, Paul Palumbo, Hartmut M. Hanauske‐Abel	2016	31
10	Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression JNCI Journal of the National Cancer Institute ·Eric C. Polley, Mark W. Kunkel, David M. Evans, Thomas Silvers, René Delosh, Julie Laudeman, Benjamin Ackermann, Russell Reinhart, Michael Selby, John Connelly, Erik Harris, Nicole Fer, Dmitriy Sonkin, Gurmeet Kaur, Anne Monks, Shakun Malik, Joel Morris, Beverly A. Teicher	2016	106
11	Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years British Journal of Clinical Pharmacology ·Francesco Bellanti, Giancarlo Vecchio, Maria Caterina Putti, Aurelio Maggio, Aldo Filosa, Akash Shaikh, Laura Mangiarini, Michael Spino, John Connelly, Adriana Ceci, Oscar Della Pasqua	2016	12
12	Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression Molecular Cancer Therapeutics ·Beverly A. Teicher, Eric C. Polley, Mark W. Kunkel, David M. Evans, Thomas Silvers, René Delosh, Julie Laudeman, Benjamin Ackermann, Russell Reinhart, Michael Selby, John Connelly, Erik Harris, Anne Monks, Joel Morris	2015	55
13	Drug-Induced Reactivation of Apoptosis Abrogates HIV-1 Infection PLoS ONE ·Hartmut M. Hanauske‐Abel, Deepti Saxena, Paul Palumbo, Kavyapriya Renganathan, Augusto Ducati Luchessi, F. Jerry Wiens, Mainul Hoque, Michael Spino, Ashwath Rohit, Debra S. Heller, Sukhwinder Singh, Myung Hee Park, Bernadette Cracchiolo, Fernando Tricta, John Connelly, Anthony Popowicz, Richard A. Cone, Bart Holland, Tsafi Pe’ery, Michael B. Mathews	2013	33
14	Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective PharmacoEconomics ·Anthony Bentley, Samantha Gillard, Michael Spino, John Connelly, Fernando Tricta	2013	16
15	Global Aquaculture Alliance on Best Aquaculture Practices: An Industry Prepares For Sustainable Growth Sustainable development law & policy ·Daniel Sang‐Hoon Lee, John Connelly	2010	4
16	Cellular Inhibition of Checkpoint Kinase 2 (Chk2) and Potentiation of Camptothecins and Radiation by the Novel Chk2 Inhibitor PV1019 [7-Nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide] Journal of Pharmacology and Experimental Therapeutics ·Andrew G. Jobson, G.T. Lountos, Philip L. Lorenzi, John Diaz Antillanca, John Connelly, David Cerna, Joseph E. Tropea, Pao Tsin Kuo, Gabriele Zoppoli, Sudhir B. Kondapaka, Guangtao Zhang, Natasha J. Caplen, John H. Cardellina, Stephen Yoo, Anne Monks, Christopher R. Self, David S. Waugh, Robert H. Shoemaker, Yves Pommier	2009	81
17	Differential Gene Expression as a Potential Classifier of 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole-Sensitive and -Insensitive Cell Lines Molecular Pharmacology ·Anders Wallqvist, John Connelly, Edward A. Sausville, David G. Covell, Anne Monks	2005	2
18	Zwischen Autonomie und Anpassung : Universitäten in den Diktaturen des 20. Jahrhunderts Bayerische Staatsbibliothek ·John Connelly, M. Kumaresan	2003	0
19	Genotoxic Profiling of MCF-7 Breast Cancer Cell Line Elucidates Gene Expression Modifications Underlying Toxicity of the Anticancer Drug 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole Molecular Pharmacology ·Anne Monks, Erik Harris, Curtis Hose, John Connelly, Edward A. Sausville	2003	47
20	Lead Concentrations in Golden and Bald Eagles Digital Commons - University of South Florida (University of South Florida) ·(unknown), John Connelly, (unknown), Marthaelena Acosta M	1990	15

About John Connelly

John Connelly is a scholar working on Virology, Genetics, Infectious Diseases, Hematology and Neurology, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include European history and politics (4 papers), Hemoglobinopathies and Related Disorders (4 papers), DNA Repair Mechanisms (3 papers), Biosensors and Analytical Detection (3 papers), HIV/AIDS drug development and treatment (3 papers), Molecular Biology Techniques and Applications (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Cardiac Structural Anomalies and Repair (2 papers). The work is most often cited by research in Hematology (134 citations), Genetics (105 citations), Neurology (76 citations), Nutrition and Dietetics (130 citations) and Neurology (124 citations). John Connelly has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Michael Spino, Fernando Tricta, Anne Monks, Antonio Martín‐Bastida, David T. Dexter, Roberta J. Ward, Maneesh C. Patel, Robert R. Crichton, David Sharp and Rexford D. Newbould. Their work appears in journals such as PLoS ONE, Molecular Cancer Therapeutics, Scientific Reports, Molecular Pharmacology and German Studies Review.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact